Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (791-800 of 1,052) with videos related to

Pageof 106
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphomaHenry C Fung, Patrick Stiff, Jeff Schriber, et al.
Journal for Immunotherapy of Cancer|January 14, 2022
Large-scale manufacturing and characterization of CMV-CD19CAR T cellsXiuli Wang, Ryan Urak, Miriam Walter, et al.
JAMA Oncology|October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal FluidJana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphomaRavi Bhatia, Khristine Van Heijzen, Ann Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2023
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expressionAshlie M Munoz, Ryan Urak, Ellie Taus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin LymphomaRobert Chen, Joycelynne M Palmer, Peter Martin, et al.
Human Immunology|March 26, 2003
Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 allelesSimon F Lacey, Maria C Villacres, Corinna La Rosa, et al.
Cancer|November 18, 2020
Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor StudyMukta Arora, Yanjun Chen, Jessica Wu, et al.
Leukemia|June 1, 2011
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemiaM H Kirschbaum, T Synold, A S Stein, et al.
Pageof 106

Showing results (791-800 of 1,052) with videos related to

Sort By:
Pageof 106
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphomaHenry C Fung, Patrick Stiff, Jeff Schriber, et al.
Journal for Immunotherapy of Cancer|January 14, 2022
Large-scale manufacturing and characterization of CMV-CD19CAR T cellsXiuli Wang, Ryan Urak, Miriam Walter, et al.
JAMA Oncology|October 8, 2020
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal FluidJana Portnow, Dongrui Wang, M Suzette Blanchard, et al.
Blood|December 9, 2000
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyM L Slovak, K J Kopecky, P A Cassileth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphomaRavi Bhatia, Khristine Van Heijzen, Ann Palmer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2023
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expressionAshlie M Munoz, Ryan Urak, Ellie Taus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin LymphomaRobert Chen, Joycelynne M Palmer, Peter Martin, et al.
Human Immunology|March 26, 2003
Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 allelesSimon F Lacey, Maria C Villacres, Corinna La Rosa, et al.
Cancer|November 18, 2020
Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor StudyMukta Arora, Yanjun Chen, Jessica Wu, et al.
Leukemia|June 1, 2011
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemiaM H Kirschbaum, T Synold, A S Stein, et al.
Pageof 106